收费全文 | 831660篇 |
免费 | 35162篇 |
国内免费 | 601篇 |
耳鼻咽喉 | 9919篇 |
儿科学 | 27891篇 |
妇产科学 | 18424篇 |
基础医学 | 128299篇 |
口腔科学 | 18149篇 |
临床医学 | 71355篇 |
内科学 | 149154篇 |
皮肤病学 | 16371篇 |
神经病学 | 63327篇 |
特种医学 | 33851篇 |
外国民族医学 | 53篇 |
外科学 | 126044篇 |
综合类 | 10496篇 |
现状与发展 | 2篇 |
一般理论 | 143篇 |
预防医学 | 63960篇 |
眼科学 | 17484篇 |
药学 | 59505篇 |
1篇 | |
中国医学 | 1950篇 |
肿瘤学 | 51045篇 |
2021年 | 5173篇 |
2019年 | 5304篇 |
2018年 | 29563篇 |
2017年 | 23084篇 |
2016年 | 26687篇 |
2015年 | 8956篇 |
2014年 | 10906篇 |
2013年 | 16571篇 |
2012年 | 29031篇 |
2011年 | 45097篇 |
2010年 | 32323篇 |
2009年 | 22719篇 |
2008年 | 42111篇 |
2007年 | 46299篇 |
2006年 | 25357篇 |
2005年 | 26182篇 |
2004年 | 26543篇 |
2003年 | 26864篇 |
2002年 | 24446篇 |
2001年 | 27628篇 |
2000年 | 29643篇 |
1999年 | 22577篇 |
1998年 | 6850篇 |
1997年 | 5726篇 |
1996年 | 5462篇 |
1995年 | 5175篇 |
1992年 | 15310篇 |
1991年 | 16642篇 |
1990年 | 16742篇 |
1989年 | 16313篇 |
1988年 | 14869篇 |
1987年 | 14836篇 |
1986年 | 13690篇 |
1985年 | 13411篇 |
1984年 | 10063篇 |
1983年 | 8575篇 |
1982年 | 4779篇 |
1979年 | 9422篇 |
1978年 | 6847篇 |
1977年 | 5621篇 |
1976年 | 5910篇 |
1975年 | 7029篇 |
1974年 | 7819篇 |
1973年 | 7499篇 |
1972年 | 6867篇 |
1971年 | 6613篇 |
1970年 | 6166篇 |
1969年 | 5721篇 |
1968年 | 5414篇 |
1967年 | 4855篇 |
Objective
Low psoas muscle area is shown to be an indicator for worse postoperative outcome in patients undergoing vascular surgical. Additionally, it has been associated with longer durations of hospital stay in patients with cancer who undergo surgery and subsequently greater health care costs in Europe and the United States. We sought to evaluate this effect on hospital expenditure for patients undergoing vascular repair in a health care system with universal access.Methods
Skeletal muscle mass was assessed on preoperative abdominal computed tomography scans of patients undergoing open aortic aneurysm repair in a retrospective fashion. The skeletal muscle index (SMI) was used to define low muscle mass. Health care costs were obtained for all patients and the relationship between a low SMI and higher costs was explored using linear regression and cross-sectional analysis.Results
We included 156 patients (81.5% male) with a median age of 72 years undergoing elective surgery for infrarenal abdominal aortic aneurysm in this analysis. The median SMI for patients with low skeletal muscle mass was 53.21 cm2/kg and for patients without, 70.07 cm2/kg. Hospital duration of stay was 2 days longer in patients with low skeletal muscle mass as compared with patients with normal (14 days vs 11 days; P = .001), as was duration of intensive care stay (3 days vs 1 day; P = .01). The median overall hospital costs were €10,460 higher for patients with a low SMI as compared with patients with a normal physical constitution (€53,739 [interquartile range, €45,007-€62,471] vs €43,279 [interquartile range, €39,509-€47,049]; P = .001). After confounder adjustment, a low SMI was associated with a 14.68% cost increase in overall hospital costs, for a cost increase of €6521.Conclusions
Low skeletal muscle mass is independently associated with higher hospital as well as intensive care costs in patients undergoing elective aortic aneurysm repair. Strategies to reduce this risk factor are warranted for these patients. 相似文献Areas covered: the principal pharmacogenetic and non-genetic differences in the pharmacology of tamoxifen and endoxifen are evaluated. To this end, references from PubMed, Embase or Web of Science, among others, were reviewed As non-genetic factors, important differences and similarities such age, or adherence to tamoxifen therapy are comprehensively illustrated. Additionally, since CYP2D6 genotypes are considered the main limitation of tamoxifen, many studies have investigated the association between the worsened clinical outcomes in patients with non-functional CYP2D6 genotypes. In this review, an overview of the research on this field is presented. Also, a summary describing the literature about individualizing tamoxifen therapy with endoxifen concentrations and its limitations is listed.
Expert opinion: z-endoxifen hydrochloride is only investigated in the metastatic setting, still more research is required before its place in therapeutics is known. Similarly, monitoring tamoxifen efficacy based on endoxifen concentrations might not be overall recommended due to the limited evidence available. 相似文献
Areas covered: This review focuses on current treatments and the future outlook for allergic rhinitis. Pharmacotherapy includes mast cell stabilizers, antihistamines, glucocorticosteroids (GCSs), leukotriene receptor antagonists, and nasal decongestants. Nasal GCSs are currently regarded as the most effective treatment and are considered first-line therapy together with non-sedating antihistamines. The new formulation MP29-02 combines the nasal GCS fluticasone propionate with azelastine in one single spray and has achieved greater improvements than those under monotherapy with modern GCSs or antihistamines. Furthermore, this review discusses allergen immunotherapy alone and in combination with modern monoclonal antibodies.
Expert opinion: Despite the variety of medications for allergic rhinitis, ranging from general symptomatic agents like GCSs or decongestants, to more specific ones like histamine receptor or leukotriene blockers, to causal therapy like immunotherapy, many patients still experience treatment failures or unsatisfactory results. The ultimate goal may be to endotype every downstream pathway separately in order to offer patients individualized, targeted therapy with specific antibodies against the respective pathway. 相似文献